CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

PanEcho is the first AI to automatically assess all key areas of heart health from ECGs with images from multiple ... therapy for sickle cell disease, Casgevy, has been given the nod for use ...

An Oxfordshire university student is among those set to receive a "transformative" gene-therapy treatment on the NHS for ...

Galen is used for cancer diagnosis and biomarker scoring and is capable of detecting more than 100 different cancer and non-cancer pathologies from medical images, according to the company.

Generative AI has radically transformed digital creation. AI image generators can produce pictures from just a few words in a prompt, and it's becoming easier than ever to find and use these programs.

On Vertex's Q4 earnings call, investors will focus on management's comments about launch preparation for Alyftrek (vanza ...

UnitedHealth reported fourth-quarter adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72.

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...